The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: A quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry

References

• Sousa MM, Saraiva MJ. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog Neurobiol 2003;71:385–400.
   PubMed Web of Science ®Google Scholar
• Said G, Planté-Bordeneuve V. Familial amyloid polyneuropathy: a clinico-pathologic study. J Neurol Sci 2009;284:149–154.
   PubMed Web of Science ®Google Scholar
• Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408–427.
   PubMed Web of Science ®Google Scholar
• Saraiva MJ, Birken S, Costa PP, Goodman DS. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 1984;74:104–119.
   PubMed Web of Science ®Google Scholar
• Buxbaum JN, Reixach N. Transthyretin: the servant of many masters. Cell Mol Life Sci 2009;66:3095–3101.
   PubMed Web of Science ®Google Scholar
• Fleming CE, Nunes AF, Sousa MM. Transthyretin: more than meets the eye. Prog Neurobiol 2009;89:266–276.
   PubMed Web of Science ®Google Scholar
• Rosen HN, Moses AC, Murrell JR, Liepnieks JJ, Benson MD. Thyroxine interactions with transthyretin: a comparison of 10 different naturally occurring human transthyretin variants. J Clin Endocrinol Metab 1993;77:370–374.
   PubMed Web of Science ®Google Scholar
• Fitch NJ, Akbari MT, Ramsden DB. An inherited non-amyloidogenic transthyretin variant, [Ser6]-TTR, with increased thyroxine-binding affinity, characterized by DNA sequencing. J Endocrinol 1991;129:309–313.
   PubMed Web of Science ®Google Scholar
• Herbert J, Wilcox JN, Pham KT, Fremeau RT Jr, Zeviani M, Dwork A, Soprano DR, et al. Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology 1986;36:900–911.
   PubMed Web of Science ®Google Scholar
• Hurshman AR, White JT, Powers ET, Kelly JW. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 2004;43:7365–7381.
   PubMed Web of Science ®Google Scholar
• Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 2003;10:160–184.
   PubMed Web of Science ®Google Scholar
• Saraiva MJ. Transthyretin amyloidosis: a tale of weak interactions. FEBS Lett 2001;498:201–203.
   PubMed Web of Science ®Google Scholar
• Quintas A, Vaz DC, Cardoso I, Saraiva MJ, Brito RM. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem 2001;276:27207–27213.
   PubMed Web of Science ®Google Scholar
• Estrada LD, Soto C. Disrupting beta-amyloid aggregation for Alzheimer disease treatment. Curr Top Med Chem 2007;7:115–126.
   PubMed Web of Science ®Google Scholar
• Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009;326:1005–1007.
   PubMed Web of Science ®Google Scholar
• Hellman U, Alarcon F, Lundgren HE, Suhr OB, Bonaiti-Pellié C, Planté-Bordeneuve V. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid 2008;15:181–186.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Costa PM, Andersson C, Asplund K, Steen L, Beckman L, Nylander PO, et al. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 1994;31:351–354.
   PubMed Web of Science ®Google Scholar
• Planté-Bordeneuve V, Carayol J, Ferreira A, Adams D, Clerget-Darpoux F, Misrahi M, Said G, Bonaïti-Pellié C. Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families. J Med Genet 2003;40:e120.
   PubMed Web of Science ®Google Scholar
• Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995;60:512–521.
   PubMed Web of Science ®Google Scholar
• Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993;43:288–294.
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Hammarström P, Matsumura M, Shimizu Y, Iwata M, Tokuda T, Ikeda S, Kelly JW. Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Lab Invest 2003;83:409–417.
   PubMed Web of Science ®Google Scholar
• Marín-Gómez LM, Gómez-Bravo MA, Barrera-Pulido L, Bernal-Bellido C, Alamo-Martínez JM, Suárez-Artacho G, Díez-Canedo JS, Sousa-Martín JM. Outcomes of domino liver transplantation: a single institution’s experience. Transplant Proc 2010;42:644–646.
   PubMedGoogle Scholar
• da Costa G, Gomes R, Correia CF, Freire A, Monteiro E, Martins A, Barroso E, et al. Identification and quantitative analysis of human transthyretin variants in human serum by Fourier transform ion-cyclotron resonance mass spectrometry. Amyloid 2009;16:201–207.
   PubMed Web of Science ®Google Scholar
• Monteiro E, Freire A, Barroso E. Familial amyloid polyneuropathy and liver transplantation. J Hepatol 2004;41:188–194.
   PubMed Web of Science ®Google Scholar
• Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006;1:2856–2860.
   PubMed Web of Science ®Google Scholar
• Gobom J, Nordhoff E, Mirgorodskaya E, Ekman R, Roepstorff P. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 1999;34:105–116.
   PubMed Web of Science ®Google Scholar
• Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, Buccianti G, Catapano AL. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr Metab Cardiovasc Dis 2009;19:129–134.
   PubMed Web of Science ®Google Scholar
• da Costa G, Guerreiro A, Correia CF, Gomes RJ, Freire A, Monteiro E, Barroso E, et al. A non-invasive method based on saliva to characterize transthyretin in familial amyloidotic polyneuropathy patients using FT-ICR high-resolution MS. Proteomics Clin Appl 2010;4:674–678.
   PubMed Web of Science ®Google Scholar
• Schneider F, Hammarström P, Kelly JW. Transthyretin slowly exchanges subunits under physiological conditions: A convenient chromatographic method to study subunit exchange in oligomeric proteins. Protein Sci 2001;10:1606–1613.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, Andersen O, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991;40:242–246.
   PubMed Web of Science ®Google Scholar
• Ihse E, Suhr OB, Hellman U, Westermark P. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J Mol Med 2011;89:171–180.
   PubMed Web of Science ®Google Scholar
• Nelson RW, McLean MA, Hutchens TW. Quantitative Determination of Proteins by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. Anal Chem 1994;66:1408–1415.
   Web of Science ®Google Scholar
• Tang K, Allman SL, Jones RB, Chen CH, Araghi S. Laser mass spectrometry of oligonucleotides with isomer matrices. Rapid Commun Mass Spectrom 1993;7:435–439.
   PubMed Web of Science ®Google Scholar
• Jespersen S, Niessen WMA, Tjaden UR, van der Greef J. Quantitative bioanalysis using matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spec 1995;30:357–364.
   Web of Science ®Google Scholar
• Harvey DJ. Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates. Mass Spectrom Rev 1999;18:349–450.
   PubMed Web of Science ®Google Scholar
• Persson S, Sönksen CP, Frigaard NU, Cox RP, Roepstorff P, Miller M. Pigments and proteins in green bacterial chlorosomes studied by matrix-assisted laser desorption ionization mass spectrometry. Eur J Biochem 2000;267:450–456.
   PubMedGoogle Scholar
• Hochleitner EO, Kastner B, Fröhlich T, Schmidt A, Lührmann R, Arnold G, Lottspeich F. Protein stoichiometry of a multiprotein complex, the human spliceosomal U1 small nuclear ribonucleoprotein: absolute quantification using isotope-coded tags and mass spectrometry. J Biol Chem 2005;280:2536–2542.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yi EC, Li XJ, Mallick P, Kelly-Spratt KS, Masselon CD, Camp DG 2nd, et al. High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol Cell Proteomics 2005;4:144–155.
   PubMed Web of Science ®Google Scholar
• Pan S, Zhang H, Rush J, Eng J, Zhang N, Patterson D, Comb MJ, Aebersold R. High throughput proteome screening for biomarker detection. Mol Cell Proteomics 2005;4:182–190.
   PubMed Web of Science ®Google Scholar
• Olsson M, Norgren N, Obayashi K, Plante-Bordeneuve V, Suhr OB, Cederquist K, Jonasson J. A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers. BMC Med Genet 2010;11:130.
   PubMed Web of Science ®Google Scholar
• Koike H, Ando Y, Ueda M, Kawagashira Y, Iijima M, Fujitake J, Hayashi M, et al. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol Sci 2009;287:178–184.
   PubMed Web of Science ®Google Scholar
• Ueda M, Misumi Y, Mizuguchi M, Nakamura M, Yamashita T, Sekijima Y, Ota K, et al. SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy. Clin Chem 2009;55:1223–1227.
   PubMed Web of Science ®Google Scholar
• Tsuchiya-Suzuki A, Yazaki M, Kametani F, Sekijima Y, Ikeda S. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met. Hum Pathol 2011;42:236–243.
   PubMed Web of Science ®Google Scholar
• Westermark P, Sletten K, Johansson B, Cornwell GG 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990;87:2843–2845.
   PubMed Web of Science ®Google Scholar
• Liepnieks JJ, Zhang LQ, Benson MD. Progression of transthyretin amyloid neuropathy after liver transplantation. Neurology 2010;75:324–327.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Ando Y, Wikström L, Rydh A, Suhr O. Discordant symptoms in monozygotic twins with familial amyloidotic polyneuropathy (FAP) (TTR Met 30). Amyloid 1997;4:178–180.
   Web of Science ®Google Scholar
• Tanaka M, Hirai S, Matsubara E, Okamoto K, Morimatsu M, Nakazato M. Familial amyloidotic polyneuropathy without familial occurrence: carrier detection by the radioimmunoassay of variant transthyretin. J Neurol Neurosurg Psychiatr 1988;51:576–578.
   PubMedGoogle Scholar
• Munar-Qués M, Pedrosa JL, Coelho T, Gusmão L, Seruca R, Amorim A, Sequeiros J. Two pairs of proven monozygotic twins discordant for familial amyloid neuropathy (FAP) TTR Met 30. J Med Genet 1999;36:629–632.
   PubMedGoogle Scholar
• Rudolph T, Kurz MW, Farbu E. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history. Clin Med Res 2008;6:80–82.
   PubMedGoogle Scholar
• Fu MX, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 1994;43:676–683.
   PubMed Web of Science ®Google Scholar
• Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 1989;264:21597–21602.
   PubMed Web of Science ®Google Scholar
• Gomes R, Sousa Silva M, Quintas A, Cordeiro C, Freire A, Pereira P, Martins A, et al. Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy. Biochem J 2005;385:339–345.
   PubMed Web of Science ®Google Scholar
• Nyhlin N, Ando Y, Nagai R, Suhr O, El Sahly M, Terazaki H, Yamashita T, et al. Advanced glycation end product in familial amyloidotic polyneuropathy (FAP). J Intern Med 2000;247:485–492.
   PubMed Web of Science ®Google Scholar